Literature DB >> 32638824

Cancer cell membrane-coated gold nanorods for photothermal therapy and radiotherapy on oral squamous cancer.

Qiang Sun1, Jinggen Wu2, Lulu Jin3, Liangjie Hong3, Fang Wang1, Zhengwei Mao3, Mengjie Wu1.   

Abstract

The combination of different modalities greatly enhances the anticancer efficacy of each treatment by combining their merits, showing promising potential in clinical translation. Herein, we fabricated cancer cell membrane-coated gold nanorods (GNR@Mem) possessing excellent photothermal transfer ability in the second near-infrared window and radiosensitizing ability under X-ray irradiation. The cancer cell membrane coating endowed the nanomedicine with stability in the physiological environment and selective homotypic targeting to specific cancer cells in vitro. Under NIR light and X-ray irradiation, the gold nanorods induced a temperature increase, reactive oxygen generation, and subsequent damage to the DNA helix structure, leading to enhanced cell apoptosis. Benefitting from its relative long circulation time in the blood and homotypic targeting effect, the tumor accumulation of GNR@Mem significantly increased. The in vivo results demonstrate that the combination of photothermal therapy and radiotherapy effectively suppresses tumor growth without noticeable systemic toxicity.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32638824     DOI: 10.1039/d0tb01063d

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  16 in total

Review 1.  Membrane-wrapped nanoparticles for nucleic acid delivery.

Authors:  Mackenzie A Scully; Eric H Sterin; Emily S Day
Journal:  Biomater Sci       Date:  2022-08-09       Impact factor: 7.590

Review 2.  Current trends of targeted therapy for oral squamous cell carcinoma.

Authors:  Hongjiao Li; Yao Zhang; Mengmeng Xu; Deqin Yang
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-02       Impact factor: 4.322

Review 3.  External and Internal Stimuli-Responsive Metallic Nanotherapeutics for Enhanced Anticancer Therapy.

Authors:  Adityanarayan Mohapatra; Saji Uthaman; In-Kyu Park
Journal:  Front Mol Biosci       Date:  2021-01-11

Review 4.  Preparation, toxicity reduction and radiation therapy application of gold nanorods.

Authors:  Lina Xie; Xujia Zhang; Chengchao Chu; Yingqi Dong; Tianzi Zhang; Xinyue Li; Gang Liu; Wen Cai; Suxia Han
Journal:  J Nanobiotechnology       Date:  2021-12-28       Impact factor: 10.435

Review 5.  Biomimetic phototherapy in cancer treatment: from synthesis to application.

Authors:  Yifan Zhao; Cuixia Shi; Jie Cao
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

6.  Ligand-modified homologous targeted cancer cell membrane biomimetic nanostructured lipid carriers for glioma therapy.

Authors:  Mengyu Chen; Yuexin Cui; Wenyan Hao; Yueyue Fan; Jingqiu Zhang; Qianqian Liu; Mingrui Jiang; Yang Yang; Yingzi Wang; Chunsheng Gao
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 7.  Cell Membrane-Cloaked Nanotherapeutics for Targeted Drug Delivery.

Authors:  Na-Hyun Lee; Sumin You; Ali Taghizadeh; Mohsen Taghizadeh; Hye Sung Kim
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

Review 8.  The Applications of Gold Nanoparticles in the Diagnosis and Treatment of Gastrointestinal Cancer.

Authors:  Zhijing Yang; Dongxu Wang; Chenyu Zhang; Huimin Liu; Ming Hao; Shaoning Kan; Dianfeng Liu; Weiwei Liu
Journal:  Front Oncol       Date:  2022-01-19       Impact factor: 6.244

9.  Iron-Palladium Decorated Carbon Nanotubes Achieve Radiosensitization via Reactive Oxygen Species Burst.

Authors:  Shengnan Yang; Yiling Yang; Yi Yang; Xiangya Zhao; Qian Wang; Bing Li; Ling Dong; Rui Tian; Zhirong Bao
Journal:  Front Bioeng Biotechnol       Date:  2021-05-21

Review 10.  Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy.

Authors:  Wen Lei; Chen Yang; Yi Wu; Guoqing Ru; Xianglei He; Xiangmin Tong; Shibing Wang
Journal:  J Nanobiotechnology       Date:  2022-01-21       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.